Clinical Trial Update: Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With Estrogen-receptor-positive (ER+), Human Epidermal Growth Factor Receptor 2 (HER2)- Metastatic or Locally Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Open-label Phase II study evaluating a steroid-based mouthwash to prevent stomatitis in post-menopausal women with ER+/HER2- metastatic or locally advanced brea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Dexamethasone mouthwash (Dexamethasone)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Advanced Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-02-13